Next Article in Journal
Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments
Next Article in Special Issue
Prolactin Rescues Immature B Cells from Apoptosis-Induced BCR-Aggregation through STAT3, Bcl2a1a, Bcl2l2, and Birc5 in Lupus-Prone MRL/lpr Mice
Previous Article in Journal
Targeting Aquaporins in Novel Therapies for Male and Female Breast and Reproductive Cancers
Previous Article in Special Issue
Complement as a Therapeutic Target in Systemic Autoimmune Diseases
Open AccessFeature PaperReview

Adipokines and Autoimmunity in Inflammatory Arthritis

Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus Liebig University Giessen, 61231 Bad Nauheim, Germany
Author to whom correspondence should be addressed.
Cells 2021, 10(2), 216;
Received: 30 November 2020 / Revised: 13 January 2021 / Accepted: 19 January 2021 / Published: 22 January 2021
(This article belongs to the Special Issue Molecular and Cellular Basis of Autoimmune Diseases)
Adipokines are adipose tissue-derived factors not only playing an important role in metabolism but also influencing other central processes of the body, such as inflammation. In autoimmune diseases, adipokines are involved in inflammatory pathways affecting different cell types. Many rheumatic diseases belong to the group of autoimmune diseases, for example rheumatoid arthritis (RA) and psoriatic arthritis. Due to the autoimmune responses, a chronic inflammatory milieu develops, which affects the whole body, including adipose tissue. Metabolic alterations such as obesity influence inflammatory responses in autoimmune diseases. Adipokines are bioactive mediators mainly produced by adipose tissue. Due to alterations of systemic adipokine levels, their role as biomarkers with diagnostic potential has been suggested in the context of rheumatic diseases. In the affected joints of RA patients, different synoviocytes but also osteoclasts, osteoblasts, and chondrocytes produce several adipokines, contributing to the unique inflammatory microenvironment. Adipokines have been shown to be potent modulatory effectors on different cell types of the immune system but also local cells in synovial tissue, cartilage, and bone. This review highlights the most recent findings on the role of adipokines in the pathophysiology of inflammatory arthritis with a distinct focus on RA in the quickly developing research field. View Full-Text
Keywords: adipokines; adipocytokines; rheumatic diseases; rheumatoid arthritis; autoimmunity adipokines; adipocytokines; rheumatic diseases; rheumatoid arthritis; autoimmunity
Show Figures

Figure 1

MDPI and ACS Style

Neumann, E.; Hasseli, R.; Ohl, S.; Lange, U.; Frommer, K.W.; Müller-Ladner, U. Adipokines and Autoimmunity in Inflammatory Arthritis. Cells 2021, 10, 216.

AMA Style

Neumann E, Hasseli R, Ohl S, Lange U, Frommer KW, Müller-Ladner U. Adipokines and Autoimmunity in Inflammatory Arthritis. Cells. 2021; 10(2):216.

Chicago/Turabian Style

Neumann, Elena; Hasseli, Rebecca; Ohl, Selina; Lange, Uwe; Frommer, Klaus W.; Müller-Ladner, Ulf. 2021. "Adipokines and Autoimmunity in Inflammatory Arthritis" Cells 10, no. 2: 216.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop